Name | 6-(2-(1-isopropyl-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl)cyclopropyl)-2-naphthalenecarboximidamide |
---|---|
Synonyms | A-317567 |
Description | A-317567 is a potent acid-sensing ion channel 3 (ASIC-3) inhibitor with an IC50 of 1.025 μM. A-317567 has antidepressant and antinociception effects[1][2]. |
---|---|
Related Catalog | |
Target |
IC50: 1.025 μM (Acid-sensing ion channel 3 (ASIC-3))[1] |
In Vitro | The effects of A-317567 on three distinct types of native ASIC currents evoked in acutely dissociated adult rat dorsal root ganglion (DRG) neurons are studied. A-317567 produces concentration-dependent inhibition of all pH 4.5-evoked ASIC currents with an IC50 ranging between 2 and 30 μM, depending upon the type of ASIC current activated. A-317567 equipotently blocks the sustained phase of ASIC3-like current, a biphasic current akin to cloned ASIC3, which is predominant in DRG[2]. |
In Vivo | A-317567 is fully analgesic effects in the CFA model (ED50 of 17 μmol/kg, i.p., adult male Sprague-Dawley rats). There is no significant effect of A-317567 on the withdrawal latency of the contralateral paw under these conditions[2]. |
References |
Molecular Formula | C27H31N3 |
---|---|
Molecular Weight | 397.55500 |
Exact Mass | 397.25200 |
PSA | 53.11000 |
LogP | 6.31790 |